Literature DB >> 20232312

Apoptosis induction by eIF5A1 involves activation of the intrinsic mitochondrial pathway.

Zhong Sun1, Zhenyu Cheng, Catherine A Taylor, Brendan J McConkey, John E Thompson.   

Abstract

The regulatory role of eukaryotic translation initiation factor 5A1 (eIF5A1) in apoptosis was examined using HT-29 and HeLa S3 cells. eIF5A is the only known protein to contain the unusual amino acid, hypusine, and eIF5A1 is one of two human eIF5A family members. Two observations indicated that eIF5A1 is involved in apoptosis. First, siRNA-mediated suppression of eIF5A1 resulted in inhibition of apoptosis induced by various apoptotic stimuli, and second, adenovirus-mediated over-expression of eIF5A1 strongly induced apoptotic cell death. A mutant of eIF5A1 incapable of being hypusinated also induced apoptosis when over-expressed indicating that unhypusinated eIF5A1 is the pro-apoptotic form of the protein. Over-expression of eIF5A1 or of the mutant resulted in loss of mitochondrial transmembrane potential, translocation of Bax to the mitochondria, release of cytochrome c, caspase activation, up-regulation of p53, and up-regulation of Bim, a pro-apoptotic BH3-only Bcl-2 family protein. In addition, Bim(L) and Bim(S), the pro-apoptotic alternative spliced forms of Bim, were induced in response to over-expression of eIF5A1. Thus eIF5A1 appears to induce apoptosis by activating the mitochondrial apoptotic pathway. Proteomic analyses indicated that, of 1,899 proteins detected, 131 showed significant changes in expression (P <or= 0.05, expression ratio >or=1.5) within 72 h of eIF5A1 up-regulation. Among these are proteins involved in translation and protein folding, transcription factors, proteins mediating proteolysis, and a variety of proteins known to be directly involved in apoptosis. These observations collectively indicate that unhypusinated eIF5A1 plays a central role in the regulation of apoptosis. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232312     DOI: 10.1002/jcp.22100

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  26 in total

1.  XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A.

Authors:  Takahito Miyake; Sunila Pradeep; Sherry Y Wu; Rajesha Rupaimoole; Behrouz Zand; Yunfei Wen; Kshipra M Gharpure; Archana S Nagaraja; Wei Hu; Min Soon Cho; Heather J Dalton; Rebecca A Previs; Morgan L Taylor; Takeshi Hisamatsu; Yu Kang; Tao Liu; Sharon Shacham; Dilara McCauley; David H Hawke; John E Wiktorowicz; Robert L Coleman; Anil K Sood
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

Review 2.  Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.

Authors:  Shima Nakanishi; John L Cleveland
Journal:  Amino Acids       Date:  2016-06-29       Impact factor: 3.520

Review 3.  Elongation factor P mediates a novel post-transcriptional regulatory pathway critical for bacterial virulence.

Authors:  S Betty Zou; Hervé Roy; Michael Ibba; William Wiley Navarre
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

4.  Biological Relevance and Therapeutic Potential of the Hypusine Modification System.

Authors:  Nora Pällmann; Melanie Braig; Henning Sievert; Michael Preukschas; Irm Hermans-Borgmeyer; Michaela Schweizer; Claus Henning Nagel; Melanie Neumann; Peter Wild; Eugenia Haralambieva; Christian Hagel; Carsten Bokemeyer; Joachim Hauber; Stefan Balabanov
Journal:  J Biol Chem       Date:  2015-06-02       Impact factor: 5.157

Review 5.  eIF5A isoforms and cancer: two brothers for two functions?

Authors:  M Caraglia; M H Park; E C Wolff; M Marra; A Abbruzzese
Journal:  Amino Acids       Date:  2011-12-03       Impact factor: 3.520

6.  Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias.

Authors:  Patrick Ziegler; Tuhama Chahoud; Thomas Wilhelm; Nora Pällman; Melanie Braig; Valeska Wiehle; Susanne Ziegler; Marcus Schröder; Chris Meier; Adrian Kolodzik; Matthias Rarey; Jens Panse; Joachim Hauber; Stefan Balabanov; Tim H Brümmendorf
Journal:  Invest New Drugs       Date:  2012-03-14       Impact factor: 3.850

7.  Modulation of eIF5A expression using SNS01 nanoparticles inhibits NF-κB activity and tumor growth in murine models of multiple myeloma.

Authors:  Catherine A Taylor; Zhongda Liu; Terence C Tang; Qifa Zheng; Sarah Francis; Tzann-Wei Wang; Bin Ye; John A Lust; Richard Dondero; John E Thompson
Journal:  Mol Ther       Date:  2012-05-15       Impact factor: 11.454

8.  A tumour suppressor network relying on the polyamine-hypusine axis.

Authors:  Claudio Scuoppo; Cornelius Miething; Lisa Lindqvist; José Reyes; Cristian Ruse; Iris Appelmann; Seungtai Yoon; Alexander Krasnitz; Julie Teruya-Feldstein; Darryl Pappin; Jerry Pelletier; Scott W Lowe
Journal:  Nature       Date:  2012-07-12       Impact factor: 49.962

9.  Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.

Authors:  Michael Preukschas; Christian Hagel; Alexander Schulte; Kristoffer Weber; Katrin Lamszus; Henning Sievert; Nora Pällmann; Carsten Bokemeyer; Joachim Hauber; Melanie Braig; Stefan Balabanov
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

10.  Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue.

Authors:  Ricardo Ribeiro; Cátia Monteiro; Victoria Catalán; Pingzhao Hu; Virgínia Cunha; Amaia Rodríguez; Javier Gómez-Ambrosi; Avelino Fraga; Paulo Príncipe; Carlos Lobato; Francisco Lobo; António Morais; Vitor Silva; José Sanches-Magalhães; Jorge Oliveira; Francisco Pina; Carlos Lopes; Rui Medeiros; Gema Frühbeck
Journal:  BMC Med       Date:  2012-09-25       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.